US Broker Ratings

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech with 35% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is garnering significant attention in the healthcare sector, specifically within biotechnology. With its strategic focus on developing transformative medicines to tackle..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 30% Potential Upside Amidst Challenging Market Conditions

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, specializes in the design and manufacture of single-use medical devices that cater to critical care..

Sarepta Therapeutics, Inc. (SRPT)

⚠️ No article content returned.

..

Charles River Laboratories (CRL): A Comprehensive Investor Outlook Amidst Technical Strengths and Financial Challenges

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a key player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Wilmington,..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Exploring Growth Potential with a 20.3% Revenue Surge

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, specifically within the medical devices industry. This San Francisco-based digital healthcare company is renowned..

Grifols, S.A. (GRFS): Investor Outlook Highlighting a 34% Potential Upside

Grifols, S.A. (NASDAQ: GRFS) is capturing the attention of investors with its strategic positioning in the healthcare sector, particularly in the drug manufacturing industry. Headquartered in..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unveiling a 15.99% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, continues to capture investor interest with its robust product offerings and promising growth..

Guardant Health, Inc. (GH) Stock Analysis: A Healthcare Innovator with an 18% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its cutting-edge diagnostic solutions. The company specializes in..

Takeda Pharmaceutical (TAK) Stock Analysis: Exploring Its 11% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, is a significant player in the drug manufacturing industry with a market cap of..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 47% Upside Potential with Robust Analyst Confidence

For investors keen on the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents an intriguing opportunity, especially given its significant potential upside. As a cutting-edge player..

Alcon Inc. (ALC) Stock Analysis: A 20.52% Upside Potential in the Healthcare Sector

Alcon Inc. (NYSE: ALC), headquartered in Geneva, Switzerland, operates at the intersection of innovation and healthcare, focusing on eye care products. With a substantial market cap..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 22.18% Potential Upside Amidst Strong Free Cash Flow and High Dividend Yield

Viatris Inc. (NASDAQ: VTRS), a notable player in the healthcare sector, stands out with a market capitalization of $10.94 billion. As a company entrenched in the..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatile Path with a $11.37 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), is capturing attention in the healthcare sector, especially within the..

Natera, Inc. (NTRA) Investor Outlook: Analyzing the 19.18% Potential Upside in Healthcare Diagnostics

Natera, Inc. (NASDAQ: NTRA) stands at the forefront of the healthcare diagnostics sector, offering a suite of innovative molecular testing services that cater to a global..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Gem with 22% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors in the healthcare sector with its robust cloud-based software solutions for healthcare payments. As the..

BioNTech SE (BNTX) Stock Analysis: Exploring Growth Potential with a 24.61% Upside

BioNTech SE (NASDAQ: BNTX), headquartered in Mainz, Germany, is a prominent player in the biotechnology sector, known for its groundbreaking contributions to immunotherapy for cancer and..

Royalty Pharma plc (RPRX) Stock Analysis: Strong Analyst Consensus with a 14% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) continues to capture the interest of investors with its unique position in the biotechnology sector. As a major player in the..

Nuvalent, Inc. (NUVL) Stock Analysis: Unveiling a 45.75% Upside Potential in the Biotech Sector

Nuvalent, Inc. (NUVL), a pioneering force in the biopharmaceutical arena, is capturing the attention of investors with its promising pipeline of cancer therapies and an impressive..

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings Signal Potential Upside in the Biotech Sector

Insmed Incorporated (NASDAQ: INSM) is making waves in the biotechnology sector with its innovative approach to treating serious and rare diseases. Headquartered in Bridgewater, New Jersey,..

Oscar Health, Inc. (OSCR) Stock Analysis: A Healthcare Innovator with 42.2% Revenue Growth and 6.21% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) has been making waves in the healthcare sector with its innovative approach to health plans and technology-driven solutions. As a company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds